Skinvisible Expands Obesity Patent Application for Transdermal Delivery [Yahoo! Finance]
SKINVISIBLE INC (SKVI)
NASDAQ:AMEX Investor Relations:
skinvisible.com/investors.html
Company Research
Source: Yahoo! Finance
LAS VEGAS, NV / ACCESSWIRE / June 24, 2024 / Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI ), an innovative topical / transdermal pharmaceutical research and development company, today announced the filing of a second patent application for its groundbreaking Invisicare ® technology and its transdermal delivery of obesity and glucose-controlling agents. This new application significantly broadens the scope of the Company's initial patent application titled "Transdermal Delivery Composition for Delivery of CB-1 Receptor Antagonists and/or GLP-1 Receptor Agonists, and Method of Delivery," previously announced in May , encompassing a wider range of active ingredients and additional conditions beyond obesity that can benefit from glucose-controlling agents such as diabetes. Patent Details and Technological Advancements The new patent application, titled "Transdermal Delivery Composition for Delivery of at Least One Glucose Controlling Agent, and Method of Delivering at Least One Glu
Show less
Read more
Impact Snapshot
Event Time:
SKVI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SKVI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SKVI alerts
High impacting SKINVISIBLE INC news events
Weekly update
A roundup of the hottest topics
SKVI
Sec Filings
- 6/4/24 - Form 8-K
- 5/29/24 - Form 8-K
- 4/1/24 - Form NT
- SKVI's page on the SEC website